Joel S. Marcus

Co-Founder at Alexandria Real Estate Equities, Inc.

Joel S. Marcus

Joel S. Marcus

Co-Founder at Alexandria Real Estate Equities, Inc.

Overview
Career Highlights

Kirin-Amgen, Inc.
Alexandria Venture Investments LLC
Alexandria Real Estate Equities, Inc.

RelSci Relationships

3800

Number of Boards

51

Birthday

1947

Age

72

Number of Awards

1

Contact Data
Trying to get in touch with Joel S. Marcus? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Joel S. Marcus likely has professional access to. A relationship does not necessarily indicate a personal connection.

President & Chief Executive Officer at Rodeo Therapeutics Corp.

Relationship likelihood: Strong

Co-Founder at Intra-Cellular Therapies, Inc.

Relationship likelihood: Strong

Vice President Pfizer Venture Investments at Pfizer, Inc.

Relationship likelihood: Strong

President & Executive Director at Foundation for the National Institutes of Health, Inc.

Relationship likelihood: Strong

Managing Director at ARCH Venture Partners

Relationship likelihood: Strong

Executive Chair at Atara Biotherapeutics, Inc.

Relationship likelihood: Strong

Co-Chief Executive Officer at Alexandria Real Estate Equities, Inc.

Relationship likelihood: Strong

Co-Chief Executive Officer & Co-Chief Investment Officer at Alexandria Real Estate Equities, Inc.

Relationship likelihood: Strong

Founder at Yumanity Therapeutics, Inc.

Relationship likelihood: Strong

Vice President, Pharmaceutical Discovery at AbbVie, Inc.

Relationship likelihood: Strong

Paths to Joel S. Marcus
Potential Connections via
Relationship Science
You
Joel S. Marcus
Co-Founder at Alexandria Real Estate Equities, Inc.
Education
BA

UCLA's primary purpose as a public research university is the creation, dissemination, preservation and application of knowledge for the betterment of our global society. To fulfill this mission, UCLA is committed to academic freedom in its fullest terms: We value open access to information, free and lively debate conducted with mutual respect for individuals, and freedom from intolerance. In all of our pursuits, we strive at once for excellence and diversity, recognizing that openness and inclusion produce true quality. These values underlie our three institutional responsibilities. Learning and teaching at UCLA are guided by the belief that undergraduate, graduate and professional school students and their teachers belong to a community of scholars. This community is dedicated to providing students with a foundational understanding of a broad range of disciplines followed by the opportunity for in-depth study in a chosen discipline. All members of the community are engaged together in discovering and advancing knowledge and practice. Learning occurs not only in the classroom but also through engagement in campus life and in communities and organizations beyond the university.

JD

UCLA School of Law is the youngest top law school in the nation. After more than 60 years, our school has never felt bound by outmoded ideas of how law should be taught or studied. Instead, beginning in the 1950s, UCLA created its own tradition - a tradition of innovation.

Memberships
Member
Current

NAREIT®, the National Association of Real Estate Investment Trusts®, is the worldwide representative voice for REITs and publicly traded real estate companies with an interest in U.S. real estate and capital markets. NAREIT's members are REITs and other businesses throughout the world that own, operate, and finance income-producing real estate, as well as those firms and individuals who advise, study, and service those businesses.

Member
Current

The participating CEOs lead companies that collectively employ more than five million people, generate more than $2 trillion in annual revenue, and represent 11 countries and a diverse group of industries.

Career History
Executive Chairman & Founder
1996 - Current

Alexandria Venture Investments LLC invests in companies located in the US. The firm targets companies operating in the fields of medical, health andlife sciences sector. They provides financing for seed, early and growth stage capital requirements.

Co-Founder
1994 - Current

Alexandria Real Estate Equities, Inc. is an urban office real estate investment trust, which engages in the ownership, operation, development, and redevelopment of life science and technology properties. It also provides a space for lease to the life science and technology industries which are primarily located in AAA urban innovation cluster locations. The company was founded by Alan D. Gold, Gary A. Kreitzer, Joel S. Marcus, and Jerry M. Sudarsky in October 1994 and is headquartered in Pasadena, CA.

Outside Advisor
Current

Emerging Technology Partners (ETP) invests in companies that develop drugs to address large unmet clinical needs, develop proprietary technology platforms that address rapidly growing markets, recruit experienced management teams with proven industry expertise and provide substantial returns on invested capital. The firm may invest as early as the seed stage and as late as pre-IPO rounds. ETP typically invests between $500,000 and $3 million in a single round, committing as much as $5 million to a company over a series of financings

Boards & Committees
Director
Current

Lodo Therapeutics Corp. develops novel therapeutics derived from its metagenomics-based small molecule discovery platform. The company was founded by Sean Brady and David L. Pompliano on November 11, 2015 and is headquartered in New York, NY.

Member, Advisory Board
Current

Established in 1998, the REIT Center provides a forum for the study the and analysis of publicly-traded REITs and other real estate operating companies and the related corporatization, securitization, and consolidation trends that are transforming the real estate industry nationally and globally. The Center’s goal is to serve as a sponsor for research, discussion, and analysis; an educational center for conferences and symposia for professionals and students; and a forum for leading thinkers from all sectors and professions in the industry to gather in order to exchange and to develop ideas. Among other activities, the Center sponsors an influential annual conference on REITs and a White Paper series. New York University’s proximity to Wall Street creates an exciting focus for the Center as we seek to complement and to work with existing industry groups and trade associations with similar interests. The mission of the Center is to fulfill a need for in-depth study and analysis in an objective academic setting and thereby, to enhance the work of other groups.

Board Observer, Board of Directors
Current

Cydan II, Inc. develops and commercializes drugs for orphan and diseases. The firm evaluates products for treating rare diseases with high unmet medical need to start multiple companies to develop such therapies. The company was founded by Cristina Csimma, James G. McArthur, Deborah S. Geraghty and Christoph M. Adams in 2013 and is headquartered in Cambridge, MA.

Director
Prior

TO DRIVE COLLABORATION AMONG PARTNERS FROM EVERY HEALTHCARE SECTOR TO POWER ADVANCES IN SCIENCE, POLICY AND REGULATION THAT SPEED LIFE-SAVING TREATMENTS TO PATIENTS.

Director
Prior

The Hamner Institutes for Health Sciences provides medical research services. Its services include preclinical safety, inhalation exposure and aerosol sciences, analytical chemistry and hepatassure services. The firm specializes in Chemical, Drug safety, Toxicology, Global partnership, Translational research, Computational modeling, Genomics, Vivarium and Biosciences Accelerator services. The company was founded in 1974 and is headquartered in Research Triangle Park, NC.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$25K - $50K
2016

The Foundation leverages NIH's science with private-sector support for biomedical advances that benefit people around the world. As a non-profit organization, the Foundation serves donors who wish to support biomedical research by building on the resources and talent at NIH in specific areas of interest. In addition, the Foundation supports training and advanced education programs for the investigators of tomorrow and invests in educational programs about medical research.

Political Donations
$1,250
2012

Senator at Office of the Senator from Utah, Mitt Romney

$2,400
2009

Director, Public Affairs at Foley & Lardner LLP

Transactions
Details Hidden

Alexandria Real Estate Equities, Inc. raised money in a private placement transaction

Details Hidden

Alexandria Real Estate Equities, Inc. raised money in a private placement transaction

Details Hidden

Alexandria Real Estate Equities, Inc. raised money in a private placement transaction

Investments
Details Hidden

AgTech Accelerator Corp. focuses on discovering and developing agricultural technology companies. It offers finance to agricultural firms. The company was founded in 2003 and is headquartered in Durham, NC.

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
CPA (Certified Public Accountant)
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Joel S. Marcus. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Joel S. Marcus's profile does not indicate a business or promotional relationship of any kind between RelSci and Joel S. Marcus.